Supraventricular tachyarrhythmias with sepsis Circulatory System Supraventricular tachycardia
Conditions
Interventions
Patients were divided into two groups: those treated with landiolol (landiolol group) and those not treated with landiolol (control group) to control HR of supraventricular tachyarrhythmias.
Patient
Sponsors
Kanazawa University Hospital (Japan)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. All patients who admitted to intensive care unit of the Kanazawa University Hospital from January 2006 to December 2011 2. Systemic inflammatory response syndrome score = 2 with infection 3. Supraventricular tachyarrhythmias with HR = 120 bpm for >1 h
Exclusion criteria
Exclusion criteria: 1. Less than 18 years old 2. History of chronic supraventricular tachyarrhythmias 3. Supraventricular tachyarrhythmias at the time of ICU admission
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HR reduction of the supraventricular tachyarrhythmias without a decrease in arterial pressure. Arterial pressure and HR were compared between the two groups at 1, 8, and 24 h after the initiation of tachyarrhythmia. | — |
Secondary
| Measure | Time frame |
|---|---|
| The frequency of conversion to sinus rhythm. Differences of conversion rates were analyzed with Fisher?s exact test or the chi-square test as appropriate. | — |
Countries
Japan
Outcome results
None listed